Carregant...
Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used As Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients?
♦ Background: Peritoneal effluent contains clinically relevant substances derived from intraperitoneal production or transperitoneal transport, or both. The glycoproteinase matrix metalloproteinase 2 (MMP-2) cleaves denatured collagen and complements other collagenases in the degradation of fibrilla...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797671/ https://ncbi.nlm.nih.gov/pubmed/23994841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/pdi.2012.01063 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|